Humacyte, Inc. Ttl Offering Amt
Humacyte, Inc. (HUMA) had Ttl Offering Amt of $3.80 million as of 2026-05-14, per its S-8 filed 2026-05-14.
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-05-14
- 2026-05-14: Ttl Offering Amt $3.80M.
| Period end | Ttl Offering Amt |
|---|---|
| 2026-05-14 | $3.80M S-8 · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |